MyFinsight
Home
Blog
About
Contact
Back
Income Statement
AN2 Therapeutics, Inc. (ANTX)
AN2 Therapeutics, Inc. (ANTX)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$10,090K
Net loss
attributable to common...
-$10,028K
Unrealized (loss) gain on
investments
-$62K
Interest income
$523K
Loss from operations
-$10,551K
Total operating
expenses
$10,551K
Research and development
$6,743K
General and
administrative
$3,808K
Back